Sandeep Wagle of powermywealth.com told CNBC-TV18, "I would recommend an exit Sun Pharma Advanced Research Company (SPARC) in the range of Rs 330-340. If you talk of the next two to three years which is a long-term investment this stock can even go to Rs 450-500 zone. So, in that sense I would recommend a hold."The share touched its 52-week high Rs 508.82 and 52-week low Rs 243.43 on 15 April, 2015 and 25 February, 2016, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
